Skip to main content

Select Drug Profiles

Original Research

Pharmacy Staff Opinions Regarding Diabetic Retinopathy Screenings in the Community Setting: Findings from a Brief Survey

Miranda G. Law, BS, PharmD Candidate, Stephanie Komura, BS, PharmD Candidate, Ann P. Murchison, MD, MPH, Laura T. Pizzi, PharmD, MPH

Stakeholder Perspective

Screening for Diabetic Retinopathy in the Community Setting: Exploring the Options

by Gary M. Owens, MD

Practice Management

Modeling the Frequency and Costs Associated with Postsurgical Gastrointestinal Adverse Events for Tapentadol IR versus Oxycodone IR

Andrew Paris, MBA, Chris M. Kozma, PhD, Wing Chow, PharmD, MPH, Anisha M. Patel, MS, Samir H. Mody, PharmD, MBA, Myoung S. Kim, PhD, MBA

Stakeholder Perspective

Can Substituting Generic Drugs with Brand-Name Agents for Acute Pain Postsurgery Help to Deliver Cost-Effective, Quality Care?

by Matthew Mitchell, PharmD, MBA, FAMCP

Practicing Population Health

David B. Nash, MD, MBA

The Affordable Care Act Conundrum: Facing Reality in America’s Giant Social Experiment

Kip Piper, MA, FACHE

PharMerica and Onco360 Finalize Strategic Investment; Establish First National Oncology Pharmacy and Care Management Platform

Cost and Drug Utilization Patterns Associated with the Management of Rosacea

Caroline Helwick

Skin Disorders the Number One Reason for Medical Visits in the United States

Caroline Helwick

Fetzima Extended-Release Receives FDA Approval for the Treatment of Major Depressive Disorder in Adults

Simponi Aria: A New Intravenous TNF Inhibitor for the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis

Conference Correspondent

A Diagnostic Test for Lupus Based on DNA Methylation Signatures from Peripheral Blood Mononuclear Cells

Page 162 of 244
Results 1611 - 1620 of 2438